Skip to content

Observational study of the effects of remimazolam on MEP in spinal surgery

Observational study of the effects of remimazolam on MEP in spinal surgery - Observational study of the effects of remimazolam on MEP in spinal surgery

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000042367
Enrollment
150
Registered
2020-11-06
Start date
2020-11-06
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spine surgery

Interventions

None listed

Sponsors

Hamamatsu University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: >General anesthesia with remimazolam >Spine surgery >intra operative monitoring of Motor Evoked Potentials

Exclusion criteria

Exclusion criteria: >declines or withdraw to consent >impairment of consciousness >child

Design outcomes

Primary

MeasureTime frame
False positive rate of Motor Evoked Potentials

Secondary

MeasureTime frame
Time required for extubation Duration ofventilation Length of stay in the intensive care unit Remifentanil dosage Fentanyl dosage

Countries

Japan

Contacts

Public ContactShingo Kawashima

Hamamatsu University School of Medicine Department of Anesthesiology and Intensive Care Medicine

shingogo@hama-med.ac.jp053-435-2738

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026